Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028377 · ClinicalTrials.gov registry record · NA
Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02028377 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 25 participants.
The verdict
NCT02028377, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will use PET/MRI in patients with adenocarcinoma of the pancreas to identify hidden metastatic disease or identify patients with borderline or locally advanced disease.
Interventions
- PROCEDURE PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-08-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02028377
The ClinicalTrials.gov registry entry for NCT02028377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET/MRI is the first listed.
NCT02028377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02028377 about?
NCT02028377 is a clinical study titled "Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma". This study will use PET/MRI in patients with adenocarcinoma of the pancreas to identify hidden metastatic disease or identify patients with borderline or locally advanced disease.
What is the current status of trial NCT02028377?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2013-02. Estimated completion is 2017-08-22.
What interventions are being tested in trial NCT02028377?
The interventions under investigation include: PET/MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02028377?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.